AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4. A total of 20 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $170,826,000 | +28.4% | 174,372,000 | +10.8% | 3.40% | +23.9% |
| Q2 2022 | $133,036,000 | -6.2% | 157,390,000 | 0.0% | 2.74% | -13.5% |
| Q1 2022 | $141,877,000 | +9.0% | 157,390,000 | 0.0% | 3.17% | +16.2% |
| Q4 2021 | $130,154,000 | -9.5% | 157,390,000 | 0.0% | 2.73% | -2.7% |
| Q3 2021 | $143,842,000 | -8.2% | 157,390,000 | 0.0% | 2.81% | +0.9% |
| Q2 2021 | $156,612,000 | +1.4% | 157,390,000 | +5.2% | 2.78% | -14.3% |
| Q1 2021 | $154,446,000 | +12.7% | 149,600,000 | 0.0% | 3.25% | +19.8% |
| Q4 2020 | $137,072,000 | +14.1% | 149,600,000 | 0.0% | 2.71% | -7.4% |
| Q3 2020 | $120,099,000 | – | 149,600,000 | – | 2.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 157,390,000 | $143,842,000 | 2.81% |
| PFM Health Sciences, LP | 48,150,000 | $44,256,000 | 1.30% |
| DAFNA Capital Management LLC | 1,500,000 | $1,375,000 | 0.36% |
| SILVERBACK ASSET MANAGEMENT LLC | 2,500,000 | $2,303,000 | 0.34% |
| Context Capital Management, LLC | 2,979 | $2,707,000 | 0.28% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 9,667,000 | $8,842,000 | 0.16% |
| DeepCurrents Investment Group LLC | 3,700,000 | $3,423,000 | 0.10% |
| LOOMIS SAYLES & CO L P | 1,249,328 | $14,242,000 | 0.02% |
| SG Americas Securities, LLC | 22,600 | $2,255,000 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 9,218,000 | $8,376,000 | 0.01% |